메뉴 건너뛰기




Volumn 126, Issue 4, 2015, Pages 445-453

Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PROGNOSIS; CHRONIC LYMPHATIC LEUKEMIA; CLONAL EVOLUTION; COPY NUMBER VARIATION; DISEASE COURSE; EPIGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENETIC HETEROGENEITY; GENOMICS; HUMAN; KARYOTYPING; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; GENETICS; PATHOLOGY;

EID: 84937856647     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-02-585042     Document Type: Review
Times cited : (117)

References (93)
  • 1
    • 84894552888 scopus 로고    scopus 로고
    • Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions
    • Goede V, Fischer K, Busch R, et al. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. N Engl J Med. 2014;370(12):1101-1110.
    • (2014) N Engl J Med , vol.370 , Issue.12 , pp. 1101-1110
    • Goede, V.1    Fischer, K.2    Busch, R.3
  • 2
    • 84896692766 scopus 로고    scopus 로고
    • Idelalisib and rituximab in relapsed chronic lymphocytic leukemia
    • Furman RR, Sharman JP, Coutre SE, et al. Idelalisib and rituximab in relapsed chronic lymphocytic leukemia. N Engl J Med. 2014;370(11):997-1007.
    • (2014) N Engl J Med , vol.370 , Issue.11 , pp. 997-1007
    • Furman, R.R.1    Sharman, J.P.2    Coutre, S.E.3
  • 3
    • 84879748062 scopus 로고    scopus 로고
    • Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia
    • Byrd JC, Furman RR, Coutre SE, et al. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med. 2013;369(1):32-42.
    • (2013) N Engl J Med , vol.369 , Issue.1 , pp. 32-42
    • Byrd, J.C.1    Furman, R.R.2    Coutre, S.E.3
  • 4
    • 84925484937 scopus 로고    scopus 로고
    • Determination of recommended phase 2 dose of ABT-199 (GDC-0199) combined with rituximab (R) in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL)
    • abstract
    • Roberts AW, Ma S, Brander DM, et al. Determination of recommended phase 2 dose of ABT-199 (GDC-0199) combined with rituximab (R) in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) [abstract]. Blood. 2014;124(21). Abstract 325.
    • (2014) Blood , vol.124 , Issue.21
    • Roberts, A.W.1    Ma, S.2    Brander, D.M.3
  • 5
    • 84904411900 scopus 로고    scopus 로고
    • Evolving understanding of the CLL genome
    • Gruber M, Wu CJ. Evolving understanding of the CLL genome. Semin Hematol. 2014;51(3):177-187.
    • (2014) Semin Hematol , vol.51 , Issue.3 , pp. 177-187
    • Gruber, M.1    Wu, C.J.2
  • 6
    • 84855370035 scopus 로고    scopus 로고
    • SF3B1 and other novel cancer genes in chronic lymphocytic leukemia
    • Wang L, Lawrence MS, Wan Y, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med. 2011;365(26):2497-2506.
    • (2011) N Engl J Med , vol.365 , Issue.26 , pp. 2497-2506
    • Wang, L.1    Lawrence, M.S.2    Wan, Y.3
  • 7
    • 79960353160 scopus 로고    scopus 로고
    • Analysis of the chronic lymphocytic leukemia coding genome: Role of NOTCH1 mutational activation
    • Fabbri G, Rasi S, Rossi D, et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med. 2011;208(7):1389-1401.
    • (2011) J Exp Med , vol.208 , Issue.7 , pp. 1389-1401
    • Fabbri, G.1    Rasi, S.2    Rossi, D.3
  • 8
    • 79960036578 scopus 로고    scopus 로고
    • Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
    • Puente XS, Pinyol M, Quesada V, et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature. 2011;475(7354):101-105.
    • (2011) Nature , vol.475 , Issue.7354 , pp. 101-105
    • Puente, X.S.1    Pinyol, M.2    Quesada, V.3
  • 9
    • 84555171449 scopus 로고    scopus 로고
    • Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
    • Quesada V, Conde L, Villamor N, et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet. 2011;44(1):47-52.
    • (2011) Nat Genet , vol.44 , Issue.1 , pp. 47-52
    • Quesada, V.1    Conde, L.2    Villamor, N.3
  • 10
    • 84878551940 scopus 로고    scopus 로고
    • POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia
    • Ramsay AJ, Quesada V, Foronda M, et al. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat Genet. 2013;45(5):526-530.
    • (2013) Nat Genet , vol.45 , Issue.5 , pp. 526-530
    • Ramsay, A.J.1    Quesada, V.2    Foronda, M.3
  • 11
    • 84886851785 scopus 로고    scopus 로고
    • Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome
    • Fabbri G, Khiabanian H, Holmes AB, et al. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome. J Exp Med. 2013;210(11):2273-2288.
    • (2013) J Exp Med , vol.210 , Issue.11 , pp. 2273-2288
    • Fabbri, G.1    Khiabanian, H.2    Holmes, A.B.3
  • 12
    • 84874102335 scopus 로고    scopus 로고
    • Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
    • Landau DA, Carter SL, Stojanov P, et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell. 2013;152(4):714-726.
    • (2013) Cell , vol.152 , Issue.4 , pp. 714-726
    • Landau, D.A.1    Carter, S.L.2    Stojanov, P.3
  • 13
    • 75649133610 scopus 로고    scopus 로고
    • Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia
    • Kanduri M, Cahill N, Göransson H, et al. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia. Blood. 2010;115(2):296-305.
    • (2010) Blood , vol.115 , Issue.2 , pp. 296-305
    • Kanduri, M.1    Cahill, N.2    Göransson, H.3
  • 14
    • 84861922114 scopus 로고    scopus 로고
    • Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia
    • Pei L, Choi J-H, Liu J, et al. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia. Epigenetics. 2012;7(6):567-578.
    • (2012) Epigenetics , vol.7 , Issue.6 , pp. 567-578
    • Pei, L.1    Choi, J.-H.2    Liu, J.3
  • 15
    • 84868198427 scopus 로고    scopus 로고
    • Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia
    • Kulis M, Heath S, Bibikova M, et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet. 2012;44(11):1236-1242.
    • (2012) Nat Genet , vol.44 , Issue.11 , pp. 1236-1242
    • Kulis, M.1    Heath, S.2    Bibikova, M.3
  • 16
    • 84873570131 scopus 로고    scopus 로고
    • 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments
    • Cahill N, Bergh A-C, Kanduri M, et al. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia. 2013;27(1):150-158.
    • (2013) Leukemia , vol.27 , Issue.1 , pp. 150-158
    • Cahill, N.1    Bergh, A.-C.2    Kanduri, M.3
  • 17
    • 84895783051 scopus 로고    scopus 로고
    • Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia
    • Oakes CC, Claus R, Gu L, et al. Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia. Cancer Discov. 2014;4(3):348-361.
    • (2014) Cancer Discov , vol.4 , Issue.3 , pp. 348-361
    • Oakes, C.C.1    Claus, R.2    Gu, L.3
  • 18
    • 84919469035 scopus 로고    scopus 로고
    • Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia
    • Landau DA, Clement K, Ziller MJ, et al. Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia. Cancer Cell. 2014;26(6):813-825.
    • (2014) Cancer Cell , vol.26 , Issue.6 , pp. 813-825
    • Landau, D.A.1    Clement, K.2    Ziller, M.J.3
  • 20
    • 84879419178 scopus 로고    scopus 로고
    • The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia
    • Malek SN. The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia. Oncogene. 2013;32(23):2805-2817.
    • (2013) Oncogene , vol.32 , Issue.23 , pp. 2805-2817
    • Malek, S.N.1
  • 21
    • 0034727833 scopus 로고    scopus 로고
    • Genomic aberrations and survival in chronic lymphocytic leukemia
    • Döhner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343(26):1910-1916.
    • (2000) N Engl J Med , vol.343 , Issue.26 , pp. 1910-1916
    • Döhner, H.1    Stilgenbauer, S.2    Benner, A.3
  • 22
    • 84863957729 scopus 로고    scopus 로고
    • Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia
    • Brown JR, Hanna M, Tesar B, et al. Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia. Clin Cancer Res. 2012;18(14):3791-3802.
    • (2012) Clin Cancer Res , vol.18 , Issue.14 , pp. 3791-3802
    • Brown, J.R.1    Hanna, M.2    Tesar, B.3
  • 23
    • 18744396337 scopus 로고    scopus 로고
    • Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
    • Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2002;99(24):15524-15529.
    • (2002) Proc Natl Acad Sci USA , vol.99 , Issue.24 , pp. 15524-15529
    • Calin, G.A.1    Dumitru, C.D.2    Shimizu, M.3
  • 24
    • 84892833777 scopus 로고    scopus 로고
    • Discovery and saturation analysis of cancer genes across 21 tumour types
    • Lawrence MS, Stojanov P, Mermel CH, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014;505(7484):495-501.
    • (2014) Nature , vol.505 , Issue.7484 , pp. 495-501
    • Lawrence, M.S.1    Stojanov, P.2    Mermel, C.H.3
  • 25
    • 84878396846 scopus 로고    scopus 로고
    • SF3B1 mutations in chronic lymphocytic leukemia
    • Wan Y, Wu CJ. SF3B1 mutations in chronic lymphocytic leukemia. Blood. 2013;121(23):4627-4634.
    • (2013) Blood , vol.121 , Issue.23 , pp. 4627-4634
    • Wan, Y.1    Wu, C.J.2
  • 26
    • 84979023963 scopus 로고    scopus 로고
    • Novel putative driver gene mutations in chronic lymphocytic leukemia (CLL): Results from a combined analysis of whole-exome sequencing of 262 primary CLL samples
    • abstract
    • Landau DA, Stewart C, Reiter JG, et al. Novel putative driver gene mutations in chronic lymphocytic leukemia (CLL): results from a combined analysis of whole-exome sequencing of 262 primary CLL samples [abstract]. Blood. 2014;124(21). Abstract 1952.
    • (2014) Blood , vol.124 , Issue.21
    • Landau, D.A.1    Stewart, C.2    Reiter, J.G.3
  • 27
    • 84874428346 scopus 로고    scopus 로고
    • Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
    • Rossi D, Rasi S, Spina V, et al. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. Blood. 2013;121(8):1403-1412.
    • (2013) Blood , vol.121 , Issue.8 , pp. 1403-1412
    • Rossi, D.1    Rasi, S.2    Spina, V.3
  • 29
    • 84891866590 scopus 로고    scopus 로고
    • SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients
    • Jeromin S, Weissmann S, Haferlach C, et al. SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients. Leukemia. 2014;28(1):108-117.
    • (2014) Leukemia , vol.28 , Issue.1 , pp. 108-117
    • Jeromin, S.1    Weissmann, S.2    Haferlach, C.3
  • 30
    • 84895798179 scopus 로고    scopus 로고
    • On the way towards a 'CLL prognostic index': Focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort
    • Cortese D, Sutton L-A, Cahill N, et al. On the way towards a 'CLL prognostic index': focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort. Leukemia. 2014;28(3):710-713.
    • (2014) Leukemia , vol.28 , Issue.3 , pp. 710-713
    • Cortese, D.1    Sutton, L.-A.2    Cahill, N.3
  • 31
    • 84871798242 scopus 로고    scopus 로고
    • Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial
    • Skowronska A, Parker A, Ahmed G, et al. Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial. J Clin Oncol. 2012;30(36):4524-4532.
    • (2012) J Clin Oncol , vol.30 , Issue.36 , pp. 4524-4532
    • Skowronska, A.1    Parker, A.2    Ahmed, G.3
  • 32
    • 84872469222 scopus 로고    scopus 로고
    • The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial
    • Oscier DG, Rose-Zerilli MJJ, Winkelmann N, et al. The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial. Blood. 2013;121(3):468-475.
    • (2013) Blood , vol.121 , Issue.3 , pp. 468-475
    • Oscier, D.G.1    Rose-Zerilli, M.J.J.2    Winkelmann, N.3
  • 33
    • 84901408966 scopus 로고    scopus 로고
    • Gene mutations and treatment outcome in chronic lymphocytic leukemia: Results from the CLL8 trial
    • Stilgenbauer S, Schnaiter A, Paschka P, et al. Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial. Blood. 2014;123(21):3247-3254.
    • (2014) Blood , vol.123 , Issue.21 , pp. 3247-3254
    • Stilgenbauer, S.1    Schnaiter, A.2    Paschka, P.3
  • 34
    • 84887204270 scopus 로고    scopus 로고
    • NOTCH1, SF3B1, and TP53 mutations in fludarabinerefractory CLL patients treated with alemtuzumab: Results from the CLL2H trial of the GCLLSG
    • Schnaiter A, Paschka P, Rossi M, et al. NOTCH1, SF3B1, and TP53 mutations in fludarabinerefractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG. Blood. 2013;122(7):1266-1270.
    • (2013) Blood , vol.122 , Issue.7 , pp. 1266-1270
    • Schnaiter, A.1    Paschka, P.2    Rossi, M.3
  • 35
    • 84879173666 scopus 로고    scopus 로고
    • TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: Six-year follow-up of the GCLLSG CLL3X trial
    • Dreger P, Schnaiter A, Zenz T, et al. TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial. Blood. 2013;121(16):3284-3288.
    • (2013) Blood , vol.121 , Issue.16 , pp. 3284-3288
    • Dreger, P.1    Schnaiter, A.2    Zenz, T.3
  • 36
    • 84937899116 scopus 로고    scopus 로고
    • Mutational landscape of 118 relapsed chronic lymphocytic leukemia clinical trial samples; evidence for a multiple-hit profile using targeted next generation sequencing
    • abstract
    • Robbe P, Guièze R, Clifford RM, et al. Mutational landscape of 118 relapsed chronic lymphocytic leukemia clinical trial samples; evidence for a multiple-hit profile using targeted next generation sequencing [abstract]. Blood. 2014;124(21). Abstract 1974.
    • (2014) Blood , vol.124 , Issue.21
    • Robbe, P.1    Guièze, R.2    Clifford, R.M.3
  • 37
    • 84906908742 scopus 로고    scopus 로고
    • Acquired initiating mutations in early hematopoietic cells of CLL patients
    • Damm F, Mylonas E, Cosson A, et al. Acquired initiating mutations in early hematopoietic cells of CLL patients. Cancer Discov. 2014;4(9):1088-1101.
    • (2014) Cancer Discov , vol.4 , Issue.9 , pp. 1088-1101
    • Damm, F.1    Mylonas, E.2    Cosson, A.3
  • 38
    • 84905990862 scopus 로고    scopus 로고
    • Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL
    • Wang L, Shalek AK, Lawrence M, et al. Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL. Blood. 2014;124(7):1089-1098.
    • (2014) Blood , vol.124 , Issue.7 , pp. 1089-1098
    • Wang, L.1    Shalek, A.K.2    Lawrence, M.3
  • 39
    • 84893699492 scopus 로고    scopus 로고
    • Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia
    • Ferreira PG, Jares P, Rico D, et al. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome Res. 2014;24(2):212-226.
    • (2014) Genome Res , vol.24 , Issue.2 , pp. 212-226
    • Ferreira, P.G.1    Jares, P.2    Rico, D.3
  • 40
    • 84929291816 scopus 로고    scopus 로고
    • The impact of SF3B1 mutations in CLL on the DNA-damage response
    • Te Raa GD, Derks IA, Navrkalova V, et al. The impact of SF3B1 mutations in CLL on the DNA-damage response. Leukemia. 2015;29(5):1133-1142.
    • (2015) Leukemia , vol.29 , Issue.5 , pp. 1133-1142
    • Te Raa, G.D.1    Derks, I.A.2    Navrkalova, V.3
  • 41
    • 84897585594 scopus 로고    scopus 로고
    • SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage
    • Clifford R, Louis T, Robbe P, et al. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. Blood. 2014;123(7):1021-1031.
    • (2014) Blood , vol.123 , Issue.7 , pp. 1021-1031
    • Clifford, R.1    Louis, T.2    Robbe, P.3
  • 42
    • 84859398461 scopus 로고    scopus 로고
    • Nurture versus nature: The microenvironment in chronic lymphocytic leukemia
    • Burger JA. Nurture versus nature: the microenvironment in chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2011;2011:96-103.
    • (2011) Hematology Am Soc Hematol Educ Program , vol.2011 , pp. 96-103
    • Burger, J.A.1
  • 43
    • 84902183019 scopus 로고    scopus 로고
    • Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib
    • Woyach JA, Furman RR, Liu TM, et al. Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib. N Engl J Med. 2014;370(24):2286-2294.
    • (2014) N Engl J Med , vol.370 , Issue.24 , pp. 2286-2294
    • Woyach, J.A.1    Furman, R.R.2    Liu, T.M.3
  • 44
    • 84899084563 scopus 로고    scopus 로고
    • Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness
    • Messina M, Del Giudice I, Khiabanian H, et al. Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness. Blood. 2014;123(15):2378-2388.
    • (2014) Blood , vol.123 , Issue.15 , pp. 2378-2388
    • Messina, M.1    Del Giudice, I.2    Khiabanian, H.3
  • 45
    • 0017167185 scopus 로고
    • The clonal evolution of tumor cell populations
    • Nowell PC. The clonal evolution of tumor cell populations. Science. 1976;194(4260):23-28.
    • (1976) Science , vol.194 , Issue.4260 , pp. 23-28
    • Nowell, P.C.1
  • 46
    • 84856013431 scopus 로고    scopus 로고
    • Clonal evolution in cancer
    • Greaves M, Maley CC. Clonal evolution in cancer. Nature. 2012;481(7381):306-313.
    • (2012) Nature , vol.481 , Issue.7381 , pp. 306-313
    • Greaves, M.1    Maley, C.C.2
  • 47
    • 57149118627 scopus 로고    scopus 로고
    • Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia
    • Mullighan CG, Phillips LA, Su X, et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science. 2008;322(5906):1377-1380.
    • (2008) Science , vol.322 , Issue.5906 , pp. 1377-1380
    • Mullighan, C.G.1    Phillips, L.A.2    Su, X.3
  • 48
    • 84878411259 scopus 로고    scopus 로고
    • Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia
    • Ouillette P, Saiya-Cork K, Seymour E, Li C, Shedden K, Malek SN. Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia. Clin Cancer Res. 2013;19(11):2893-2904.
    • (2013) Clin Cancer Res , vol.19 , Issue.11 , pp. 2893-2904
    • Ouillette, P.1    Saiya-Cork, K.2    Seymour, E.3    Li, C.4    Shedden, K.5    Malek, S.N.6
  • 49
    • 84863393080 scopus 로고    scopus 로고
    • Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
    • Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366(10):883-892.
    • (2012) N Engl J Med , vol.366 , Issue.10 , pp. 883-892
    • Gerlinger, M.1    Rowan, A.J.2    Horswell, S.3
  • 50
    • 84862526929 scopus 로고    scopus 로고
    • The clonal and mutational evolution spectrum of primary triple-negative breast cancers
    • Shah SP, Roth A, Goya R, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature. 2012;486(7403):395-399.
    • (2012) Nature , vol.486 , Issue.7403 , pp. 395-399
    • Shah, S.P.1    Roth, A.2    Goya, R.3
  • 51
    • 84862776906 scopus 로고    scopus 로고
    • Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
    • Ding L, Ley TJ, Larson DE, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012;481(7382):506-510.
    • (2012) Nature , vol.481 , Issue.7382 , pp. 506-510
    • Ding, L.1    Ley, T.J.2    Larson, D.E.3
  • 52
    • 84991237207 scopus 로고    scopus 로고
    • Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia
    • Wang J, Khiabanian H, Rossi D, et al. Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia. ELife. 2014;3.
    • (2014) ELife , pp. 3
    • Wang, J.1    Khiabanian, H.2    Rossi, D.3
  • 53
    • 73649116987 scopus 로고    scopus 로고
    • The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia
    • Klein U, Lia M, Crespo M, et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell. 2010;17(1):28-40.
    • (2010) Cancer Cell , vol.17 , Issue.1 , pp. 28-40
    • Klein, U.1    Lia, M.2    Crespo, M.3
  • 54
    • 84920024296 scopus 로고    scopus 로고
    • Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
    • Genovese G, Kähler AK, Handsaker RE, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371(26):2477-2487.
    • (2014) N Engl J Med , vol.371 , Issue.26 , pp. 2477-2487
    • Genovese, G.1    Kähler, A.K.2    Handsaker, R.E.3
  • 55
    • 84920053873 scopus 로고    scopus 로고
    • Age-related clonal hematopoiesis associated with adverse outcomes
    • Jaiswal S, Fontanillas P, Flannick J, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488-2498.
    • (2014) N Engl J Med , vol.371 , Issue.26 , pp. 2488-2498
    • Jaiswal, S.1    Fontanillas, P.2    Flannick, J.3
  • 56
    • 80051589767 scopus 로고    scopus 로고
    • Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia
    • Kikushige Y, Ishikawa F, Miyamoto T, et al. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell. 2011;20(2):246-259.
    • (2011) Cancer Cell , vol.20 , Issue.2 , pp. 246-259
    • Kikushige, Y.1    Ishikawa, F.2    Miyamoto, T.3
  • 57
    • 84945940347 scopus 로고    scopus 로고
    • Subclonal driver mutations predict shorter progression free survival in chronic lymphocytic leukemia following first-line chemo(immuno) therapy: Results from the CLL8 trial
    • abstract
    • Landau DA, Tausch E, Taylor-Weiner AN, et al. Subclonal driver mutations predict shorter progression free survival in chronic lymphocytic leukemia following first-line chemo(immuno) therapy: results from the CLL8 trial [abstract]. Blood. 2014;124(21). Abstract 1938.
    • (2014) Blood , vol.124 , Issue.21
    • Landau, D.A.1    Tausch, E.2    Taylor-Weiner, A.N.3
  • 58
    • 84863785266 scopus 로고    scopus 로고
    • Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia
    • Knight SJL, Yau C, Clifford R, et al. Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia. Leukemia. 2012;26(7):1564-1575.
    • (2012) Leukemia , vol.26 , Issue.7 , pp. 1564-1575
    • Knight, S.J.L.1    Yau, C.2    Clifford, R.3
  • 59
    • 84863774653 scopus 로고    scopus 로고
    • Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse
    • Braggio E, Kay NE, VanWier S, et al. Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse. Leukemia. 2012;26(7):1698-1701.
    • (2012) Leukemia , vol.26 , Issue.7 , pp. 1698-1701
    • Braggio, E.1    Kay, N.E.2    VanWier, S.3
  • 60
    • 84869753284 scopus 로고    scopus 로고
    • Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns
    • Schuh A, Becq J, Humphray S, et al. Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. Blood. 2012;120(20):4191-4196.
    • (2012) Blood , vol.120 , Issue.20 , pp. 4191-4196
    • Schuh, A.1    Becq, J.2    Humphray, S.3
  • 61
    • 84961289235 scopus 로고    scopus 로고
    • Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia
    • Ojha J, Ayres J, Secreto C, et al. Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia. Blood. 2015;125(3):492-498.
    • (2015) Blood , vol.125 , Issue.3 , pp. 492-498
    • Ojha, J.1    Ayres, J.2    Secreto, C.3
  • 62
    • 60549113518 scopus 로고    scopus 로고
    • B-cell clones as early markers for chronic lymphocytic leukemia
    • Landgren O, Albitar M, Ma W, et al. B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med. 2009;360(7):659-667.
    • (2009) N Engl J Med , vol.360 , Issue.7 , pp. 659-667
    • Landgren, O.1    Albitar, M.2    Ma, W.3
  • 63
    • 84926984290 scopus 로고    scopus 로고
    • Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression
    • Ojha J, Secreto C, Rabe K, et al. Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression. Leukemia. 2014;28(12):2395-2398.
    • (2014) Leukemia , vol.28 , Issue.12 , pp. 2395-2398
    • Ojha, J.1    Secreto, C.2    Rabe, K.3
  • 64
    • 84925229458 scopus 로고    scopus 로고
    • Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
    • Eirew P, Steif A, Khattra J, et al. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. Nature. 2015;518(7539):422-426.
    • (2015) Nature , vol.518 , Issue.7539 , pp. 422-426
    • Eirew, P.1    Steif, A.2    Khattra, J.3
  • 65
    • 84902668801 scopus 로고    scopus 로고
    • Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
    • Patel AP, Tirosh I, Trombetta JJ, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344(6190):1396-1401.
    • (2014) Science , vol.344 , Issue.6190 , pp. 1396-1401
    • Patel, A.P.1    Tirosh, I.2    Trombetta, J.J.3
  • 66
    • 84900529199 scopus 로고    scopus 로고
    • Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq
    • Treutlein B, Brownfield DG, Wu AR, et al. Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq. Nature. 2014;509(7500):371-375.
    • (2014) Nature , vol.509 , Issue.7500 , pp. 371-375
    • Treutlein, B.1    Brownfield, D.G.2    Wu, A.R.3
  • 67
    • 84891861044 scopus 로고    scopus 로고
    • Clonal evolution in hematological malignancies and therapeutic implications
    • Landau DA, Carter SL, Getz G, Wu CJ. Clonal evolution in hematological malignancies and therapeutic implications. Leukemia. 2014;28(1):34-43.
    • (2014) Leukemia , vol.28 , Issue.1 , pp. 34-43
    • Landau, D.A.1    Carter, S.L.2    Getz, G.3    Wu, C.J.4
  • 68
    • 84902163170 scopus 로고    scopus 로고
    • Clonal evolution in patients with chronic lymphocytic leukemia (CLL) developing resistance to BTK inhibition
    • abstract
    • Burger JA, Landau D, Hoellenriegel J, et al. Clonal evolution in patients with chronic lymphocytic leukemia (CLL) developing resistance to BTK inhibition [abstract]. Blood. 2013;122(21). Abstract 866.
    • (2013) Blood , vol.122 , Issue.21
    • Burger, J.A.1    Landau, D.2    Hoellenriegel, J.3
  • 69
    • 80053144962 scopus 로고    scopus 로고
    • A decade of exploring the cancer epigenome - Biological and translational implications
    • Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011;11(10):726-734.
    • (2011) Nat Rev Cancer , vol.11 , Issue.10 , pp. 726-734
    • Baylin, S.B.1    Jones, P.A.2
  • 70
    • 79959674418 scopus 로고    scopus 로고
    • Epigenetics of haematopoietic cell development
    • Cedar H, Bergman Y. Epigenetics of haematopoietic cell development. Nat Rev Immunol. 2011;11(7):478-488.
    • (2011) Nat Rev Immunol , vol.11 , Issue.7 , pp. 478-488
    • Cedar, H.1    Bergman, Y.2
  • 71
    • 0037076279 scopus 로고    scopus 로고
    • Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression
    • Bichi R, Shinton SA, Martin ES, et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA. 2002;99(10):6955-6960.
    • (2002) Proc Natl Acad Sci USA , vol.99 , Issue.10 , pp. 6955-6960
    • Bichi, R.1    Shinton, S.A.2    Martin, E.S.3
  • 72
    • 69449100327 scopus 로고    scopus 로고
    • Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia
    • Chen S-S, Raval A, Johnson AJ, et al. Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2009;106(32):13433-13438.
    • (2009) Proc Natl Acad Sci USA , vol.106 , Issue.32 , pp. 13433-13438
    • Chen, S.-S.1    Raval, A.2    Johnson, A.J.3
  • 73
    • 0035100284 scopus 로고    scopus 로고
    • TCL1 is activated by chromosomal rearrangement or by hypomethylation
    • Yuille MR, Condie A, Stone EM, et al. TCL1 is activated by chromosomal rearrangement or by hypomethylation. Genes Chromosomes Cancer. 2001;30(4):336-341.
    • (2001) Genes Chromosomes Cancer , vol.30 , Issue.4 , pp. 336-341
    • Yuille, M.R.1    Condie, A.2    Stone, E.M.3
  • 74
    • 34249314024 scopus 로고    scopus 로고
    • Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia
    • Raval A, Tanner SM, Byrd JC, et al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell. 2007;129(5):879-890.
    • (2007) Cell , vol.129 , Issue.5 , pp. 879-890
    • Raval, A.1    Tanner, S.M.2    Byrd, J.C.3
  • 75
    • 84904011188 scopus 로고    scopus 로고
    • Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia
    • Claus R, Lucas DM, Ruppert AS, et al. Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia. Blood. 2014;124(1):42-48.
    • (2014) Blood , vol.124 , Issue.1 , pp. 42-48
    • Claus, R.1    Lucas, D.M.2    Ruppert, A.S.3
  • 76
    • 70350452269 scopus 로고    scopus 로고
    • miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia
    • Pallasch CP, Patz M, Park YJ, et al. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood. 2009;114(15):3255-3264.
    • (2009) Blood , vol.114 , Issue.15 , pp. 3255-3264
    • Pallasch, C.P.1    Patz, M.2    Park, Y.J.3
  • 77
    • 84864856010 scopus 로고    scopus 로고
    • Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia
    • Baer C, Claus R, Frenzel LP, et al. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. Cancer Res. 2012;72(15):3775-3785.
    • (2012) Cancer Res , vol.72 , Issue.15 , pp. 3775-3785
    • Baer, C.1    Claus, R.2    Frenzel, L.P.3
  • 78
    • 84876830254 scopus 로고    scopus 로고
    • Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB
    • Garding A, Bhattacharya N, Claus R, et al. Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB. PLoS Genet. 2013;9(4):e1003373.
    • (2013) PLoS Genet , vol.9 , Issue.4
    • Garding, A.1    Bhattacharya, N.2    Claus, R.3
  • 79
    • 84655162785 scopus 로고    scopus 로고
    • Regions of focal DNA hypermethylation and longrange hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains
    • Berman BP, Weisenberger DJ, Aman JF, et al. Regions of focal DNA hypermethylation and longrange hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat Genet. 2011;44(1):40-46.
    • (2011) Nat Genet , vol.44 , Issue.1 , pp. 40-46
    • Berman, B.P.1    Weisenberger, D.J.2    Aman, J.F.3
  • 80
    • 84882884517 scopus 로고    scopus 로고
    • Charting a dynamic DNA methylation landscape of the human genome
    • Ziller MJ, Gu H, Müller F, et al. Charting a dynamic DNA methylation landscape of the human genome. Nature. 2013;500(7463):477-481.
    • (2013) Nature , vol.500 , Issue.7463 , pp. 477-481
    • Ziller, M.J.1    Gu, H.2    Müller, F.3
  • 81
    • 84875745673 scopus 로고    scopus 로고
    • Interplay between the cancer genome and epigenome
    • Shen H, Laird PW. Interplay between the cancer genome and epigenome. Cell. 2013;153(1):38-55.
    • (2013) Cell , vol.153 , Issue.1 , pp. 38-55
    • Shen, H.1    Laird, P.W.2
  • 82
    • 84858414016 scopus 로고    scopus 로고
    • Regulated noise in the epigenetic landscape of development and disease
    • Pujadas E, Feinberg AP. Regulated noise in the epigenetic landscape of development and disease. Cell. 2012;148(6):1123-1131.
    • (2012) Cell , vol.148 , Issue.6 , pp. 1123-1131
    • Pujadas, E.1    Feinberg, A.P.2
  • 83
    • 77957664665 scopus 로고    scopus 로고
    • Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: A randomised, openlabel, phase 3 trial
    • Hallek M, Fischer K, Fingerle-Rowson G, et al International Group of Investigators; German Chronic Lymphocytic Leukaemia Study Group. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, openlabel, phase 3 trial. Lancet. 2010;376(9747):1164-1174.
    • (2010) Lancet , vol.376 , Issue.9747 , pp. 1164-1174
    • Hallek, M.1    Fischer, K.2    Fingerle-Rowson, G.3
  • 84
    • 84899087266 scopus 로고    scopus 로고
    • Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
    • Rossi D, Khiabanian H, Spina V, et al. Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia. Blood. 2014;123(14):2139-2147.
    • (2014) Blood , vol.123 , Issue.14 , pp. 2139-2147
    • Rossi, D.1    Khiabanian, H.2    Spina, V.3
  • 86
    • 84924668392 scopus 로고    scopus 로고
    • Efficacy and safety of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic leukemia with 17p deletion: Results from the phase II RESONATE™-17 trial
    • abstract
    • O'Brien S, Jones JA, Coutre S, et al. Efficacy and safety of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic leukemia with 17p deletion: results from the phase II RESONATE™-17 trial [abstract]. Blood. 2014;124(21). Abstract 327.
    • (2014) Blood , vol.124 , Issue.21
    • O'Brien, S.1    Jones, J.A.2    Coutre, S.3
  • 87
    • 84924378555 scopus 로고    scopus 로고
    • Second interim analysis of a phase 3 study of idelalisib (ZYDELIG®) plus rituximab (R) for relapsed chronic lymphocytic leukemia (CLL): Efficacy analysis in patient subpopulations with Del(17p) and other adverse prognostic factors
    • abstract
    • Sharman JP, Coutre SE, Furman RR, et al. Second interim analysis of a phase 3 study of idelalisib (ZYDELIG®) plus rituximab (R) for relapsed chronic lymphocytic leukemia (CLL): efficacy analysis in patient subpopulations with Del(17p) and other adverse prognostic factors [abstract]. Blood. 2014;124(21). Abstract 330.
    • (2014) Blood , vol.124 , Issue.21
    • Sharman, J.P.1    Coutre, S.E.2    Furman, R.R.3
  • 88
    • 84907284539 scopus 로고    scopus 로고
    • Evolution of ibrutinib resistance in chronic lymphocytic leukemia (CLL)
    • Komarova NL, Burger JA, Wodarz D. Evolution of ibrutinib resistance in chronic lymphocytic leukemia (CLL). Proc Natl Acad Sci USA. 2014;111(38):13906-13911.
    • (2014) Proc Natl Acad Sci USA , vol.111 , Issue.38 , pp. 13906-13911
    • Komarova, N.L.1    Burger, J.A.2    Wodarz, D.3
  • 89
    • 84925797465 scopus 로고    scopus 로고
    • Haematological malignancies: At the forefront of immunotherapeutic innovation
    • Bachireddy P, Burkhardt UE, Rajasagi M, Wu CJ. Haematological malignancies: at the forefront of immunotherapeutic innovation. Nat Rev Cancer. 2015;15(4):201-215.
    • (2015) Nat Rev Cancer , vol.15 , Issue.4 , pp. 201-215
    • Bachireddy, P.1    Burkhardt, U.E.2    Rajasagi, M.3    Wu, C.J.4
  • 91
    • 77958020833 scopus 로고    scopus 로고
    • The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: A retrospective study from the EBMT registry
    • Michallet M, Sobh M, Milligan D, et al Chronic Leukemia Working Party of the EBMT. The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry. Leukemia. 2010;24(10):1725-1731.
    • (2010) Leukemia , vol.24 , Issue.10 , pp. 1725-1731
    • Michallet, M.1    Sobh, M.2    Milligan, D.3
  • 92
    • 84883532609 scopus 로고    scopus 로고
    • Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells
    • Burkhardt UE, Hainz U, Stevenson K, et al. Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells. J Clin Invest. 2013;123(9):3756-3765.
    • (2013) J Clin Invest , vol.123 , Issue.9 , pp. 3756-3765
    • Burkhardt, U.E.1    Hainz, U.2    Stevenson, K.3
  • 93
    • 80051720194 scopus 로고    scopus 로고
    • Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia
    • Porter DL, Levine BL, Kalos M, Bagg A, June CH. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med. 2011;365(8):725-733.
    • (2011) N Engl J Med , vol.365 , Issue.8 , pp. 725-733
    • Porter, D.L.1    Levine, B.L.2    Kalos, M.3    Bagg, A.4    June, C.H.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.